Studies in healthy volunteers do not show any electrocardiographic effects with esomeprazole

Clinical Drug Investigation

Volumn 20, Issue 6, 2000, Pages 425-431

  Hasselgren, B ^a   Claar Nilsson, C ^a   Hasselgren, G ^a   Niazi, M ^a   Svernhage, E ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLATULENCE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QT INTERVAL; RR INTERVAL; T WAVE;

EID: 0034544842     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200020060-00005     Document Type: Article

References (21)

1. The dilemma of the prolonged QT interval in early drug studies
2. The long QT syndrome: A critical review
3. Cisapride-induced torsades de pointes
4. Torsade de pointes induced by cisapride/clarithromycin interaction
5. Cardiotoxic effects of astemizole overdose in children
6. Mechanism of the cardiotoxic actions of terfenadine
7. QT prolongation and recurrent 'Torsade de pointes' during erythromycin lactobionate infusion
8. Electocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs
9. Proton pump inhibitors: Pharmacology and rationale for use in gastrointestinal disorders
10. Esomeprazole provides improved acid control versus omeprazole in patients with symptoms of gastro-oesophageal reflux disease
11. An analysis of the time-relations of the electrocardiogram
12. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography
13. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
14. Rate-corrected QT interval: Techniques and limitations
15. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
16. The QT interval and drug-associated torsades de pointes
17. Variability of the QTc interval: Impact on defining drug effect and low-frequency cardiac event
18. Exploring the hidden danger of noncardiac drugs
19. Pharmacokinetic study of esomeprazole in the elderly